REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model
Psoriasis is a chronic inflammatory skin disease characterized by epidermal hyperplasia and cellular infiltration. Studies have shown that disease development depends on proinflammatory cytokines, such as interleukin (IL)-23 and IL-17. It has been suggested that IL-23 produced by innate immune cells...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/550fd90ff8164fe1becb6007a39dfb22 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:550fd90ff8164fe1becb6007a39dfb22 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:550fd90ff8164fe1becb6007a39dfb222021-11-14T04:29:13ZREV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model0753-332210.1016/j.biopha.2021.112283https://doaj.org/article/550fd90ff8164fe1becb6007a39dfb222021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0753332221010672https://doaj.org/toc/0753-3322Psoriasis is a chronic inflammatory skin disease characterized by epidermal hyperplasia and cellular infiltration. Studies have shown that disease development depends on proinflammatory cytokines, such as interleukin (IL)-23 and IL-17. It has been suggested that IL-23 produced by innate immune cells, such as macrophages, stimulates a subset of helper T cells to release IL-17, promoting neutrophil recruitment and keratinocyte proliferation. However, recent studies have revealed the crucial role of γδT cells in psoriasis pathogenesis as the primary source of dermal IL-17. The nuclear receptors REV-ERBs are ligand-dependent transcription factors recognized as circadian rhythm regulators. REV-ERBs negatively regulate IL-17-producing helper T cells, whereas the involvement of REV-ERBs in regulating IL-17-producing γδT (γδT17) cells remains unclear. Here we revealed the regulatory mechanism involving γδT17 cells through REV-ERBs. γδT17 cell levels were remarkably elevated in the secondary lymphoid organs of mice that lacked an isoform of REV-ERBs. A synthetic REV-ERB agonist, SR9009, suppressed γδT17 cells in vitro and in vivo. Topical application of SR9009 to the skin reduced the inflammatory symptoms of psoriasiform dermatitis in mice. The results of this study provide a novel therapeutic approach for psoriasis targeting REV-ERBs in γδT17 cells.Shangyi WangMina KozaiHironobu MitaZimeng CaiMd. Abdul MasumOsamu IchiiKensuke TakadaMutsumi InabaElsevierarticleIL-17γδT cellsPsoriasisNuclear receptorREV-ERBTherapeutics. PharmacologyRM1-950ENBiomedicine & Pharmacotherapy, Vol 144, Iss , Pp 112283- (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
IL-17 γδT cells Psoriasis Nuclear receptor REV-ERB Therapeutics. Pharmacology RM1-950 |
| spellingShingle |
IL-17 γδT cells Psoriasis Nuclear receptor REV-ERB Therapeutics. Pharmacology RM1-950 Shangyi Wang Mina Kozai Hironobu Mita Zimeng Cai Md. Abdul Masum Osamu Ichii Kensuke Takada Mutsumi Inaba REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model |
| description |
Psoriasis is a chronic inflammatory skin disease characterized by epidermal hyperplasia and cellular infiltration. Studies have shown that disease development depends on proinflammatory cytokines, such as interleukin (IL)-23 and IL-17. It has been suggested that IL-23 produced by innate immune cells, such as macrophages, stimulates a subset of helper T cells to release IL-17, promoting neutrophil recruitment and keratinocyte proliferation. However, recent studies have revealed the crucial role of γδT cells in psoriasis pathogenesis as the primary source of dermal IL-17. The nuclear receptors REV-ERBs are ligand-dependent transcription factors recognized as circadian rhythm regulators. REV-ERBs negatively regulate IL-17-producing helper T cells, whereas the involvement of REV-ERBs in regulating IL-17-producing γδT (γδT17) cells remains unclear. Here we revealed the regulatory mechanism involving γδT17 cells through REV-ERBs. γδT17 cell levels were remarkably elevated in the secondary lymphoid organs of mice that lacked an isoform of REV-ERBs. A synthetic REV-ERB agonist, SR9009, suppressed γδT17 cells in vitro and in vivo. Topical application of SR9009 to the skin reduced the inflammatory symptoms of psoriasiform dermatitis in mice. The results of this study provide a novel therapeutic approach for psoriasis targeting REV-ERBs in γδT17 cells. |
| format |
article |
| author |
Shangyi Wang Mina Kozai Hironobu Mita Zimeng Cai Md. Abdul Masum Osamu Ichii Kensuke Takada Mutsumi Inaba |
| author_facet |
Shangyi Wang Mina Kozai Hironobu Mita Zimeng Cai Md. Abdul Masum Osamu Ichii Kensuke Takada Mutsumi Inaba |
| author_sort |
Shangyi Wang |
| title |
REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model |
| title_short |
REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model |
| title_full |
REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model |
| title_fullStr |
REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model |
| title_full_unstemmed |
REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model |
| title_sort |
rev-erb agonist suppresses il-17 production in γδt cells and improves psoriatic dermatitis in a mouse model |
| publisher |
Elsevier |
| publishDate |
2021 |
| url |
https://doaj.org/article/550fd90ff8164fe1becb6007a39dfb22 |
| work_keys_str_mv |
AT shangyiwang reverbagonistsuppressesil17productioningdtcellsandimprovespsoriaticdermatitisinamousemodel AT minakozai reverbagonistsuppressesil17productioningdtcellsandimprovespsoriaticdermatitisinamousemodel AT hironobumita reverbagonistsuppressesil17productioningdtcellsandimprovespsoriaticdermatitisinamousemodel AT zimengcai reverbagonistsuppressesil17productioningdtcellsandimprovespsoriaticdermatitisinamousemodel AT mdabdulmasum reverbagonistsuppressesil17productioningdtcellsandimprovespsoriaticdermatitisinamousemodel AT osamuichii reverbagonistsuppressesil17productioningdtcellsandimprovespsoriaticdermatitisinamousemodel AT kensuketakada reverbagonistsuppressesil17productioningdtcellsandimprovespsoriaticdermatitisinamousemodel AT mutsumiinaba reverbagonistsuppressesil17productioningdtcellsandimprovespsoriaticdermatitisinamousemodel |
| _version_ |
1718430013252960256 |